Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04497597
Other study ID # P20-095
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 16, 2020
Est. completion date May 15, 2024

Study information

Verified date January 2023
Source AbbVie
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. Despite the range of treatment options for RA steadily increasing, many patients remain sub-optimally managed, with sustained clinical remission rarely achieved. This study will assess the treatment patterns, achievement of treatment targets and maintenance of response. Upadacitinib is a drug approved for the treatment of moderately to severely active rheumatoid arthritis. Adult participants with moderate to severe RA who have been prescribed upadacitinib by their physicians will be enrolled. Approximately, 1660 participants will be enrolled this study, worldwide. Participants will not receive Upadacitinib as part of this study, but will be followed for response to treatment for up to 24 months. There may be higher burden for participants in this trial compared to their standard of care. Participants will attend regular visits, every 3 months, during the course of the study at a hospital or clinic and will be asked to provide additional information by questionnaire at each visit.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1532
Est. completion date May 15, 2024
Est. primary completion date May 15, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Confirmed diagnosis of moderate to severe active Rheumatoid Arthritis (RA). - Physician decision on patient treatment with upadacitinib must have been reached prior to and independently of recruitment in the study. - Upadacitinib prescribed in accordance to the applicable approved label and local regulatory and reimbursement policies. - French Participants Only: Taking oral glucocorticoids =5 mg/day of prednisone or equivalent for at least 3 months prior to study start. Exclusion Criteria: - Prior treatment with Upadacitinib.

Study Design


Locations

Country Name City State
Argentina CIER Centro de Investigaciones en Enfermedades Reumaticas /ID# 231769 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires
Argentina DOM Centro de Reumatologia /ID# 222194 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires
Argentina Organizacion Medica de Investigacion (OMI) /ID# 222187 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires
Argentina Instituto Medico Strusberg /ID# 222189 Cordoba
Argentina Hospital Italiano La Plata /ID# 222190 La Plata Buenos Aires
Argentina CER Instituto Medico /ID# 222193 Quilmes Buenos Aires
Argentina Instituto CAICI S.R.L /ID# 222191 Rosario Santa Fe
Argentina Cimer /Id# 222188 San Miguel de Tucuman
Argentina Instituto de Cardiologia /ID# 226634 Santiago Del Estero
Australia Private Practice - Scott Walter Graf /ID# 223958 Adelaide
Australia Genesis Research Services /ID# 224060 Broadmeadow New South Wales
Australia Emeritus Research /ID# 223883 Camberwell Victoria
Australia Joint West Rheumatology /ID# 223886 Murdoch Western Australia
Australia BJC Health /ID# 223884 Paramatta New South Wales
Austria Dr. Georg Kurtz /ID# 225477 Gleisdorf Steiermark
Austria Ordination Dr. Leeb /ID# 224293 Hollabrunn Niederoesterreich
Austria Klinikum Klagenfurt am Woerthersee /ID# 239628 Klagenfurt Am Woerthersee Kaernten
Austria Dr. Maya Thun /ID# 224299 Vienna Wien
Austria Ordination Doz. Grisar /ID# 224298 Vienna Wien
Austria Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 227853 Vienna Wien
Belgium Algemeen Stedelijk Ziekenhuis /ID# 224121 Aalst Oost-Vlaanderen
Belgium Onze Lieve Vrouw Hospital /ID# 223042 Aalst
Belgium AZ Sint Lucas /ID# 223093 Brugge
Belgium AZ Sint-Jan Brugge /ID# 223713 Brugge
Belgium CHU Saint Pierre /ID# 223041 Bruxelles Bruxelles-Capitale
Belgium Rhumaconsult SPRL /ID# 221825 Charleroi Hainaut
Belgium Reumacentrum /ID# 222799 Genk
Belgium ReumaClinic /ID# 221353 Genk
Belgium Maertens, Gistel, BE /ID# 221823 Gistel
Belgium CHU UCL Namur - site Godinne /ID# 222797 Godinne Namur
Belgium Reuma Instituut Hasselt /ID# 221822 Hasselt
Belgium CHU de Liege /ID# 222201 Liege
Belgium AZ Alma Campus Sijsele /ID# 222214 Sijsele
Belgium Private practice Sint-Niklaas /ID# 224123 Sint-Niklaas
France CH du Pays d'AIX /ID# 229561 Aix En Provence Cedex 1
France Cabinet medical /ID# 225366 Aix les Bains
France Cabinet medical /ID# 224850 Albi
France CHU Amiens-Picardie Site Sud /ID# 222444 Amiens CEDEX 1 Somme
France Centre Hospitalier d'Angouleme /ID# 226064 Angouleme CEDEX 9
France Cabinet Novel d'Annecy /ID# 232310 Annecy
France Centre Hospitalier d'Arras /ID# 223172 Arras
France CHU de Besancon - Jean Minjoz /ID# 222463 Besancon Doubs
France Hopital Avicenne - APHP /ID# 224248 Bobigny Ile-de-France
France CHU Bordeaux - Hopital Pellegrin /ID# 224837 Bordeaux
France Centre Hospitalier de Boulogne Sur Mer /ID# 222991 Boulogne sur Mer
France Hopital de la Cavale Blanche /ID# 222462 Brest
France cabinet liberal- Dr CORNILLE /ID# 227869 Caen
France Centre Hospitalier Jean Rougie /ID# 224242 Cahors
France Infirmerie Protestante /ID# 222438 Caluire Et Cuire Rhone
France CH Cannes - les Broussailles /ID# 226160 Cannes CEDEX Alpes-Maritimes
France CHRU Tours - Hopital Trousseau /ID# 222445 Chambray Les Tours
France Centre Hospitalier de CHOLET /ID# 222455 Cholet
France Hia Percy /Id# 225642 Clamart
France CHU Clermont Ferand - Hopital Gabriel Montpied /ID# 223801 Clermont Ferrand
France Cabinet liberal - Compiegne - Dr Banse /ID# 227099 Compiegne
France C. H. Sud Francilien /ID# 222446 Corbeil Essonnes
France CHU Dijon /ID# 223799 Dijon Cote-d Or
France Cabinet medical /ID# 225142 Haguenau
France CHD Vendée- La Roche-sur-Yon - Les Oudairies /ID# 229086 La Roche Sur Yon
France CH La Rochelle - Hopital Saint Louis /ID# 224240 La Rochelle
France CHU Grenoble - Hopital Michallon /ID# 223211 La Tronche
France Centre Hospitalier de Laon /ID# 224857 Laon CEDEX
France CH Emile Roux Le Puy en Velay /ID# 223688 Le Puy en Velay
France Cabinet médical /ID# 225000 Les Abrets En Dauphine
France CHU Lille - Hôpital Roger Salengro /ID# 223170 Lille
France CHU Limoges - Dupuytren 1 /ID# 222457 Limoges CEDEX 1 Franche-Comte
France Clinique de la Sauvegarde /ID# 223424 Lyon
France Hopital Saint Joseph /ID# 227221 Marseille Bouches-du-Rhone
France Cabinet de rhumatologie /ID# 227740 Mennecy
France CH Princesse Grace /ID# 222451 Monaco
France Ch Montauban /Id# 231854 Montauban
France ELSAN - Clinique du Pont de Chaume /ID# 224898 Montauban
France Clinique Beau Soleil /ID# 224238 Montpellier
France CHU Montpellier - Hôpital Saint Eloi /ID# 222452 Montpellier Cedex 5 Herault
France CHU Montpellier - Hôpital Saint Eloi /ID# 223394 Montpellier Cedex 5 Herault
France CH des Pays de Morlaix /ID# 223795 Morlaix
France Polyclinique saint Odilon /ID# 225576 Moulins
France Ch Mulhouse /Id# 223442 Mulhouse
France CHU de Nantes, Hotel Dieu -HME /ID# 225787 Nantes Pays-de-la-Loire
France CHU Nice -Hopital Pasteur /ID# 222460 Nice CEDEX 1 Provence-Alpes-Cote-d Azur
France CH Georges Renon /ID# 225197 Niort CEDEX Deux-Sevres
France CHR Orleans - Hopital de la Source /ID# 223591 Orleans CEDEX 2 Loiret
France AP-HP - Hopital Bichat - Claude-Bernard /ID# 222449 Paris
France AP-HP - Hopital Cochin /ID# 222986 Paris
France AP-HP - Hopital Saint-Antoine /ID# 222441 Paris
France Cabinet medical /ID# 224855 Paris
France Centre de Soins Osteoarticulaires Ambulatoires /ID# 224737 Paris
France GH Diaconesses Croix Saint-Simon /ID# 229126 Paris
France Hopital Pitie Salpetriere /ID# 222443 Paris
France Cabinet libéral du Dr PAUPIERE /ID# 238723 Peronne Somme
France HCL - Hopital Lyon Sud /ID# 222447 Pierre Benite CEDEX Auvergne-Rhone-Alpes
France Cabinet médical /ID# 225321 Reims
France CHU de Rennes - Hospital Sud /ID# 222458 Rennes CEDEX 2
France CH Roanne /ID# 224729 Roanne
France CH Roubaix - Hopital Victor Provo /ID# 225032 Roubaix Cedex 1 Hauts-de-France
France Clinique Saint-Hilaire /ID# 223833 Rouen
France Hôpital Charles-Nicolle /ID# 223589 Rouen
France Hôpital d'instruction des armées Bégin /ID# 222440 Saint-Mandé cedex
France Cabinet rhumatologie Dr NECTOUX /ID# 225828 Sainte Maxime
France Cabinet Rhumatologie St Michel Sur Orge /ID# 225176 St Michel Sur Orge
France CH Saint Nazaire /ID# 225750 St Nazaire
France CHU de SAINT ETIENNE - Hopital Nord /ID# 222456 St. Priest En Jarez Loire
France CHU Strasbourg - Hopital de Hautepierre /ID# 222450 Strasbourg Bas-Rhin
France Groupe Médical Spécialisé - Le Premium /ID# 223719 Strasbourg
France CH Bigorre - Site de la Gespe /ID# 225141 Tarbes CEDEX 9 Hautes-Pyrenees
France Cabinet de Rhumatologie Poincare /ID# 224755 Thionville
France CHU Toulouse - Hopital Purpan /ID# 223150 TOULOUSE Cedex 9 Haute-Garonne
Germany ACURA Rheumazentrum Baden-Bade /ID# 225225 Baden-baden
Germany Rheumapraxis Prof Dr Karin Manger /ID# 224086 Bamberg
Germany Praxis fuer Rheumatologie und Innere Medizin /ID# 225222 Berlin
Germany Eisterhues, Braunschweig, DE /ID# 225186 Braunschweig
Germany Dres. Karger/Baerlecken /ID# 224809 Cologne
Germany Rheumatologie in Veedel /ID# 224999 Cologne
Germany Praxis Dilltal /ID# 226925 Ehringshausen
Germany MVZ Ambulantes Rheumazentrum Erfurt /ID# 224812 Erfurt
Germany Helios Fachklinik Vogelsang-Gommern /ID# 222949 Gommern
Germany Heilig, Heidelberg, DE /ID# 225223 Heidelberg
Germany Praxis internistische Rheumatologie /ID# 239226 Leipzig
Germany Dres. Teipel/Toussaint/Saech /ID# 226923 Leverkusen
Germany Aurich & Sieburg, Magdeburg /ID# 230701 Magdeburg
Germany Die Fachaerzte im Rottal - Nephrologie, Rheumatologie /ID# 223866 Pfarrkirchen
Germany MVZ für Rheumatologie Dr. M. Welcker GmbH /ID# 226926 Planegg
Germany Knappschaftsklinikum Saar /ID# 225224 Puettlingen
Germany Rheumatologische-Immunologische Praxis Templin /ID# 226924 Templin Brandenburg
Germany Krankenhaus der Barmherzigen Brueder Trier /ID# 226927 Trier
Germany Praxis Dr. Haas /ID# 225187 Tuebingen
Greece University General Hospital of Alexandroupolis /ID# 224880 Alexandroupoli Evros
Greece 251 Airforce General Hospital /ID# 225065 Athens Attiki
Greece General Hospital Asklepieio Voulas /ID# 224131 Athens Attiki
Greece General Hospital of Athens Gennimatas /ID# 225064 Athens Attiki
Greece General Hospital of Athens Ippokratio /ID# 224164 Athens Attiki
Greece Naval Hospital of Athens /ID# 224135 Athens
Greece University General Hospital Attikon /ID# 224136 Athens Attiki
Greece University General Hospital of Heraklion PA.G.N.I /ID# 224133 Heraklion Kriti
Greece General Hospital of Patras Agios Andreas /ID# 224132 Patras
Greece Olympion General Clinic SA /ID# 224130 Patras
Greece Bioclinic Thessaloniki /ID# 224879 Thessaloniki
Greece Euromedica General Clinic /ID# 224134 Thessaloniki
Greece General Hospital of Thessaloniki Hippokrateio /ID# 229965 Thessaloniki
Ireland Hermitage Medical Clinic /ID# 239556 Dublin 20 Dublin
Ireland St James Hospital /ID# 224201 Dublin 8 Dublin
Ireland St Vincent's University Hospital /ID# 224200 Elm Park Dublin
Ireland Tallaght University Hospital /ID# 231260 Tallaght Dublin
Israel HaEmek Medical Center /ID# 222138 Afula
Israel Hillel Yaffe Medical Center /ID# 222170 Hadera
Israel Rambam Health Care Campus /ID# 222118 Haifa
Israel The Lady Davis Carmel Medical Center /ID# 223851 Haifa
Israel Meir Medical Center /ID# 222116 Kfar Saba
Israel Galilee Medical Center /ID# 222113 Nahariya
Israel Rabin Medical Center /ID# 222694 Petakh Tikva
Israel The Chaim Sheba Medical Center /ID# 222034 Ramat Gan Tel-Aviv
Israel Tel Aviv Sourasky Medical Center /ID# 222117 Tel Aviv-Yafo Tel-Aviv
Italy Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo /ID# 228889 Alessandria
Italy Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 229440 Ancona
Italy ASL 3 Genovese - Ospedale la Colletta /ID# 228892 Arenzano Genova
Italy Azienda Ospedaliera Universitaria Consorziale Policlinico /ID# 228580 Bari
Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni /ID# 228967 Bergamo
Italy ASST Spedali civili di Brescia /ID# 228970 Brescia
Italy Ospedale Ss. Annunziata /ID# 228809 Chieti
Italy Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant Anna /ID# 228788 Cona Ferrara
Italy ASST Gaetano Pini/Presidio Ospedaliero Pini /ID# 228556 Milan
Italy Ospedale San Raffaele IRCCS /ID# 229059 Milan Milano
Italy ASST Grande Ospedale Metropolitano Niguarda /ID# 228807 Milano
Italy Azienda Ospedaliero-Universitaria di Modena /ID# 228554 Modena
Italy AOU Universita degli Studi della Campania Luigi Vanvitelli /ID# 229057 Napoli
Italy Ospedale San Giovanni Bosco /ID# 228552 Napoli
Italy Azienda Ospedaliera Civico Di Cristina Benfratelli- P.O. Civico /ID# 228912 Palermo
Italy Azienda Ospedaliera Universitaria Paolo Giaccone /ID# 228160 Palermo
Italy Fondazione IRCCS Policlinico /ID# 227937 Pavia
Italy Azienda Ospedaliero Universitaria Pisana-Stabilimento di Santa Chiara /ID# 228550 Pisa
Italy Azienda Ospedaliera Regionale San Carlo /ID# 228648 Potenza
Italy Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 228014 Rome Lazio
Italy Azienda Ospedaliero-Universitaria Sant'Andrea /ID# 227942 Rome
Italy Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 229061 Rome Lazio
Italy Fondazione Policlinico Universitario Campus Bio-Medico di Roma /ID# 229063 Rome Lazio
Italy Istituto Clinico Humanitas /ID# 227943 Rozzano Milano
Italy Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona /ID# 229065 Salerno
Italy Azienda Ospedaliero-Universitaria Senese-Ospedale Santa Maria delle Scotte /ID# 227938 Siena
Italy A.0.Ordine Mauriziano/Ospedale Umberto I di Torino /ID# 228888 Turin
Italy Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 228551 Udine
Italy Azienda Ospedaliera Universitaria di Verona/Ospedale Borgo Trento /ID# 228553 Verona
Kuwait Mubarak Hospital /ID# 224139 Hawalli
Kuwait KOC Hospital /ID# 224138 Kuwait
Kuwait Ameeri Hospital /ID# 224140 Kuwait City
Mexico Centro de Estudios de Investigación Básica y Clínica, S.C. /ID# 224364 Guadalajara Jalisco
Mexico Centro Integral en Reumatologia S.A de C.V /ID# 224363 Guadalajara Jalisco
Mexico Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 224361 Guadalajara Jalisco
Mexico Private Office Dr. Orozco /ID# 243257 Guadalajara Jalisco
Mexico Centro Especializado en Diabetes, Obesidad y Prevencion de Enfermedades Cardiova /ID# 224360 Mexico City
Mexico CINTRE, Centro de Investigación y Tratamiento Reumatológico SC /ID# 240836 Mexico City Ciudad De Mexico
Mexico RM Pharma Specialists S.A de C.V. /ID# 224359 Mexico City Ciudad De Mexico
Mexico Consultorio Medico Privado - Miryam Eguia Bernal /Id# 243255 Monterrey Nuevo Leon
Mexico Consultorio Privado Jorge Rojas Serrano /Id# 243258 Puebla
Russian Federation District clinical hospital /ID# 227662 Khanty-Mansyisk
Russian Federation City Clinical Hospital #52 /ID# 242947 Moscow
Russian Federation Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 224852 Moscow Moskovskaya Oblast
Russian Federation Omsk Regional Clinic Hospital /ID# 232029 Omsk
Russian Federation Orenburg State Medical University /ID# 243615 Orenburg
Russian Federation Republican hospital named after V.A. Baranov /ID# 227661 Petrozavodsk
Russian Federation Clinic of Samara State Medical University /ID# 241168 Samara
Russian Federation Samara Regional Clinical Hospital n.a. V. D. Seredavin /ID# 227852 Samara Samarskaya Oblast
Russian Federation Clinical Rheumatologic Hospital No 25 /ID# 242475 St. Petersburg
Russian Federation Military Medical Academy n.a. Kirov /ID# 242351 St. Petersburg
Russian Federation Nort-Western State Medical University n.a. Mechnikov /ID# 223419 St. Petersburg Sankt-Peterburg
Russian Federation Budgetary Institution of the Khanty-Mansiysk Autonomous Okrug-Yugra "Surgut Dist /ID# 243313 Surgut
Russian Federation LLC MC RevmaMed /ID# 239162 Syktyvkar Komi, Respublika
Russian Federation Nebbiolo Clinical Research Center /ID# 224900 Tomsk
Russian Federation GBUZ TO Regional Clinical Hospital No. 1 /ID# 241113 Tyumen Tyumenskaya Oblast
Russian Federation Ulyanovsk Regional Clinical Hospital /ID# 239164 Ulyanovsk
Russian Federation Voronezh State Medical Univers /ID# 224854 Voronezh
Russian Federation Yaroslavl State Medicat University /ID# 224851 Yaroslavl
Saudi Arabia International Medical Center /ID# 243235 Jeddah
Saudi Arabia King Abdulaziz University Hospital /ID# 222724 Jeddah
Saudi Arabia Saudi German Hospital Jeddah /ID# 243234 Jeddah
Saudi Arabia Saudi German Hospital /ID# 224137 Mushait
Saudi Arabia King Fahad Medical City /ID# 222917 Riyadh
Spain Hospital Universitario A Coruna - CHUAC /ID# 231818 A Coruna
Spain Hospital Universitario Torrecardenas /ID# 241931 Almeria
Spain Hospital Perpetuo Socorro /ID# 231827 Badajoz
Spain Hospital General de Granollers /ID# 238778 Barcelona
Spain Hospital Parc de Salut del Mar /ID# 240000 Barcelona
Spain Hospital Santa Creu i Sant Pau /ID# 231821 Barcelona
Spain Hospital Ernest Lluch Martin /ID# 238779 Calatayud Zaragoza
Spain Hospital General Universitario Santa Lucia /ID# 238780 Cartagena Murcia
Spain Hospital Universitario Reina Sofia /ID# 231843 Cordoba
Spain Hospital Clinico Universitario Virgen de la Arrixaca /ID# 231847 El Palmar Murcia
Spain Hospital Universitario de Getafe /ID# 231825 Getafe Madrid
Spain Hospital Universitario Virgen de las Nieves /ID# 231841 Granada
Spain Hospital Juan Ramon Jimenez /ID# 231840 Huelva
Spain Hospital Universitario de Jaen /ID# 231842 Jaen
Spain Hospital Universitario de Jerez de la Frontera /ID# 231844 Jerez de la Frontera Cadiz
Spain Hospital Rafael Mendez /ID# 231846 Lorca Murcia
Spain Hospital Universitario Ramon y Cajal /ID# 241901 Madrid
Spain Hospital Universitario Virgen de la Victoria /ID# 240150 Malaga
Spain Hospital de Mérida /ID# 231826 Mérida Badajoz
Spain Hospital Virgen del Puerto /ID# 240149 Plasencia Caceres
Spain Hospital Universitario Canarias /ID# 231848 San Cristóbal de La Laguna Santa Cruz De Tenerife
Spain Hospital Universitario Virgen de Valme /ID# 231838 Sevilla
Spain Hospital Universitario Virgen del Rocio /ID# 231836 Sevilla
Spain Hospital Universitario Virgen Macarena /ID# 231837 Sevilla
Spain Hospital Universitario Mutua Terrassa /ID# 231822 Terrasa Barcelona
Spain Hospital Xeral Cies (CHUVI) /ID# 231819 Vigo Pontevedra
Spain Hospital de Viladecans /ID# 231823 Viladecans Barcelona
Spain Hospital Royo Villanova /ID# 231824 Zaragoza
Switzerland Kantonsspital Aarau AG /ID# 222354 Aarau Aargau
Switzerland Universitätsspital Basel /ID# 224160 Basel Basel-Stadt
Switzerland Inselspital, Universitätsspital Bern /ID# 224951 Bern
Switzerland HFR Fribourg - Hôpital cantonal /ID# 224163 Fribourg
Switzerland CHUV, Centre hospitalier universitaire vaudois /ID# 224161 Lausanne Vaud
Switzerland Kantonsspital St. Gallen /ID# 224158 St. Gallen Sankt Gallen
Switzerland Rheumatologisches Versorgungszentrum Weinfelden /ID# 222346 Weinfelden Thurgau
Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 241052 Kaohsiung
Taiwan China Medical University Hospital /ID# 241051 Taichung City
Taiwan Chi-Mei Medical Center /ID# 241745 Tainan
Taiwan National Taiwan University Hospital /ID# 241050 Taipei City
Taiwan Tri-Service General Hospital /ID# 241746 Taipei City
Taiwan Linkou Chang Gung Memorial Hospital /ID# 241053 Taoyuan City
United Arab Emirates Cleveland Clinic Abu Dhabi /ID# 223176 Abu Dhabi
United Arab Emirates Departnent of Medicine-Rheumatology Al Baraha Hospital and Al Qasmi Hospital Min /ID# 223178 Dubai
United Arab Emirates Drt Sulaiman Al Habib Hospital /ID# 226575 Dubai
United Arab Emirates Integrated Rheumatology and Arthritis Center /ID# 223177 Dubai
Uruguay Asociacion Española /ID# 222009 Montevideo
Uruguay Medica Uruguaya /ID# 222008 Montevideo

Sponsors (1)

Lead Sponsor Collaborator
AbbVie

Countries where clinical trial is conducted

Argentina,  Australia,  Austria,  Belgium,  France,  Germany,  Greece,  Ireland,  Israel,  Italy,  Kuwait,  Mexico,  Russian Federation,  Saudi Arabia,  Spain,  Switzerland,  Taiwan,  United Arab Emirates,  Uruguay, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants Who Achieve Remission Remission is defined as Disease Activity Score at 28 joints (DAS28) C-reactive Protein (CRP)<2.6. At Month 6
Primary Percentage of Participants Who Achieve Remission at 6 Months and Maintain Remission Remission is defined as DAS28-CRP<2.6. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. At Month 12
Secondary Percentage of Participants Who Achieve Remission at 6 Months and Maintain Remission Remission is defined as DAS28-CRP<2.6. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. At Month 24
Secondary Percentage of Participants Who Achieve Low Disease Activity (LDA) at 6 months that maintain LDA LDA is defined as DAS28-CRP=3.2. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. Through Month 24
Secondary Percentage of Participants Who Achieve Remission at 3 Months and Maintain Remission Remission is defined as DAS28-CRP<2.6. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. Through Month 24
Secondary Percentage of Participants Who Achieve Remission at 6 Months and Maintain Remission Grouped by Glucocorticoid Dose Remission is defined as DAS28-CRP<2.6. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. At Month 12
Secondary Percentage of Participants Who Achieve LDA at 3 months that maintain LDA Grouped by Glucocorticoid Dose LDA is defined as DAS28-CRP=3.2. Maintaining remission is defined as no more than 0.6 point increase in DAS28-CRP. Through Month 6
Secondary Percentage of Participants in LDA that Achieve Glucocorticoid Dose <5 mg/Day Per Visit LDA is defined as DAS28-CRP<3.2. Through Month 24
Secondary Percentage of Participants in Remission that Achieve Glucocorticoid Dose <5 mg/Day Per Visit Remission is defined as DAS28-CRP<2.6. Through Month 24
Secondary Percentage of Participants Who Achieved a Glucocorticoid Dose <5 mg/Day Without Conventional Synthetic Disease Modifying Anti Rheumatic Drug (csDMARD) Intensification Percentage of participants who achieved a glucocorticoid dose <5 mg/day without csDMARD intensification. At Month 6
Secondary Percentage of Participants Who Initiated Upadacitinib as Combination Therapy (csDMARD +/- Glucocorticoids) That Moved to Monotherapy (+/- Glucocorticoids) Percentage of participants who initiated Upadacitinib as combination therapy (csDMARD +/- Glucocorticoids) that moved to monotherapy (+/- glucocorticoids). Through Week 24
Secondary Of the Participants Initiating Upadacitinib as Combination Therapy (csDMARD +/- Glucocorticoids) and Achieve Remission at 6 months, the Percentage of Participants that Maintain Remission Grouped by Maintenance of Combination Therapy Strategy Remission is defined as DAS28-CRP<2.6. Through Month 24
Secondary Of the Participants Initiating Upadacitinib as Combination Therapy (csDMARD +/- Glucocorticoids) and Achieve LDA at 6 months, the Percentage of Participants that Maintain LDA Grouped by Maintenance of Combination Therapy Strategy LDA is defined as DAS28-CRP<3.2. Through Month 24
Secondary Of the Participants Initiating Upadacitinib as Monotherapy Therapy (+/- Glucocorticoids) and Achieve Remission at 6 months, the Percentage of Participants that Maintain Remission Grouped by Maintenance of Monotherapy Remission is defined as DAS28-CRP<2.6. Through Month 24
Secondary Of the Participants Initiating Upadacitinib as Monotherapy Therapy (+/- Glucocorticoids) and Achieve LDA at 6 months, the Percentage of Participants that Maintain LDA Grouped by Maintenance of Monotherapy LDA is defined as DAS28-CRP<3.2. Through Month 24
Secondary Percentage of Participants Who Do Not Achieve Remission at Any Point in the Study Remission is defined as DAS28-CRP<2.6. Through Month 24
Secondary Time to the Discontinuation of Upadacitinib Time to the discontinuation of Upadacitinib. Through Month 24
Secondary Time to First Treatment Adjustment Treatment Adjustment is defined as treatment escalation/de-escalation/ addition/withdrawal. Baseline (Month 0) Through Month 24
Secondary Percentage of Participants Achieving LDA Grouped by Therapy Strategy LDA is defined as DAS28-CRP<3.2, Simplified Disease Activity Index (SDAI) =11 and Clinical Disease Activity Index (CDAI) =10. Through Month 24
Secondary Percentage of Participants Achieving Remission Grouped by Therapy Strategy Remission is defined as DAS28-CRP<2.6, SDAI=3.3 and CDAI =2.8. Through Month 24
Secondary Change in Medication Burden Treatment Burden Questionnaire (TBQ) in Participants, Grouped by Therapy Strategy The TBQ is composed of 13 items rated on a Likert scale ranging from 0 (not a problem), to 10 (big problem). scores can be summed into a global score, ranging from 0 to 130. Through Week 24
Secondary Change in Physical Function Health Assessment Questionnaire - Disability Index (HAQ-DI) in Participants, Grouped by Therapy Strategy HAQ is a widely accepted, validated, rheumatology specific instrument to assess physical function in Rheumatoid Arthritis. It consists of 20 questions, covering eight types of activities. For each question, scores range from 0 to 3 (0 = without any difficulty; 1 = with some difficulty; 2 = with much difficulty or with assistance; 3 = unable to do). HAQ Disability Index (HAQ-DI) score is the average of the highest score in each of the eight categories. Baseline (Month 0) Through Month 24
Secondary Change in Pain Visual Analogue Scale (VAS) in participants, Grouped by Therapy Strategy A VAS is used to assess worst joint pain in the past 7 days. Baseline (Month 0) Through Month 24
Secondary Change in Morning Stiffness in Participants, Grouped by Therapy Strategy A numeric rating scale (NRS) is used to assess severity and length of morning stiffness in the past 7 days. Baseline (Month 0) Through Month 24
Secondary Change in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) in Participants, Grouped by Therapy Strategy The FACIT Fatigue Scale is a short, 13-item, easy to administer tool that measures an individual's level of fatigue during their usual daily activities over the past week. The level of fatigue is measured on a four-point Likert scale (0 = not at all fatigued to 4 = very much fatigued). Baseline (Month 0) Through Month 24
See also
  Status Clinical Trial Phase
Completed NCT05047341 - A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 Phase 1
Withdrawn NCT02786563 - Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate
Completed NCT03257852 - A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate Phase 2
Completed NCT03660059 - A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) Phase 3
Recruiting NCT03971253 - Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Not yet recruiting NCT05486715 - Vitamin d Level and it's Association With Disease Activity in Egyptian Rheumatoid Arthritis Patients
Completed NCT03682705 - A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis Phase 2
Active, not recruiting NCT04574492 - A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis
Active, not recruiting NCT02805010 - Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously Phase 1
Completed NCT01871961 - Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient Phase 1
Terminated NCT02775656 - UCB Cimzia Pregnancy Follow-up Study
Completed NCT01173120 - Methotrexate - Inadequate Response Device Sub-Study Phase 3
Completed NCT03223012 - Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service
Completed NCT03086343 - A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs Phase 3
Terminated NCT01569152 - Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) Phase 2
Completed NCT02105129 - A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 Phase 1
Completed NCT01618955 - Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device Phase 2
Completed NCT01577563 - Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). N/A
Completed NCT01618968 - Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device Phase 2
Completed NCT03339089 - Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

External Links